Quickly
Socially
Trending
CryptoNITI AAYOG
Novavax COVID-19 Vaccine Results Are Promising, Hope US-Based Company Starts Trial on Children Soon, Says Niti Aayog Member Dr VK Paul
Novavax COVID-19 Vaccine Very Safe and Highly Effective, Results Are Promising, Says Dr VK Paul
NITI Aayog Report Highlights India’s Potential To Cut 10 Gigatonnes Of C02 Emissions Over Next Three Decades
NITI Aayog, Piramal Foundation Launch 'Surakshit Hum Surakshit Tum' Abhiyaan in 112 Districts
‘Our Vaccines Are Effective on COVID-19 Mutants Seen in India Till Date’, Says NITI Aayog Member (Health) VK Paul and AIIMS Director Randeep Guleria
COVID-19 Vaccination: India Has Overtaken US In Number Of People Who Took First Shot Of Coronavirus Vaccine, Says Dr. VK Paul
COVID-19 Vaccination in India: Adequate Vaccines To Be Available in the Country From August 2021 Onwards, Says NITI Aayog CEO Amitabh Kant
Kerala Retains Top Rank in NITI Aayog's Sustainable Development Goals India Index 2020-21, Bihar at the Bottom
Mixing of COVID-19 Vaccines Not Protocol Yet, No Change in Schedule of Two-Dose Vaccines Covishield and Covaxin, Clarifies Centre
Health Ministry & NITI Aayog On Covishield-Covaxin Vaccine Mix-Up In Uttar Pradesh; ‘Significant Effect Unlikely If Doses Mixed,’ Says Centre
Covaxin Phase II and III Clinical Trials for 2–18 Age Group To Begin in 10–12 Days, Says Niti Aayog Member VK Paul
Google Trends
Live Bot